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Gender differences in first episode psychotic mania
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Patrick D McGorry1,2 and Philippe Conus7
Abstract
Background: The aim of this paper was to delineate the impact of gender on premorbid history, onset, and 18
month outcomes of first episode psychotic mania (FEPM) patients.
Methods: Medical file audit assessment of 118 (male = 71; female = 47) patients with FEPM aged 15 to 29 years
was undertaken on clinical and functional measures.
Results: Males with FEPM had increased likelihood of substance use (OR = 13.41, p < .001) and forensic issues
(OR = 4.71, p = .008), whereas females were more likely to have history of sexual abuse trauma (OR = 7.12, p = .001). At
service entry, males were more likely to be using substances, especially cannabis (OR = 2.15, p = .047), had more severe
illness (OR = 1.72, p = .037), and poorer functioning (OR = 0.96, p = .045). During treatment males were more likely to
decrease substance use (OR = 5.34, p = .008) and were more likely to be living with family (OR = 4.30, p = .009). There
were no gender differences in age of onset, psychopathology or functioning at discharge.
Conclusions: Clinically meaningful gender differences in FEPM were driven by risk factors possibly associated with
poor outcome. For males, substance use might be associated with poorer clinical presentation and functioning. In
females with FEPM, the impact of sexual trauma on illness course warrants further consideration.
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Background
Gender differences in incidence, pre-illness characteristics,
onset and course have been widely documented in psych-
otic disorders such as schizophrenia [1-4]. Less is known
regarding gender differences in bipolar I disorder. There
are epidemiological studies indicating substantive gender
differences in the incidence, presentation and course of bi-
polar I disorder; however, the extent of these differences is
yet to be fully delineated. An equal gender ratio has been
reported for bipolar I disorders [5]; however, other studies
indicate that males may be more likely to be at risk of bi-
polar I disorder [6], or conversely that there is a higher in-
cidence of bipolar I disorder in females [7].
There have been inconsistencies regarding age of illness
onset for bipolar I disorder with some studies reporting
absence of gender differences in age of onset [8], while
others have documented an earlier onset in females [9] or
an earlier onset in males [7,10]. The age range of patients
included in cohorts is an important issue. Gender differ-
ences in age of onset of bipolar disorder may vary depend-
ing on the decade under investigation. Between 16–25
years of age, bipolar disorder may be more common in
males, whereas across the other decades, females with bi-
polar disorder may predominate [7,11]. Developmental
variations across the lifespan including cortical matur-
ation, psychosocial development, and changes in the
female reproductive cycle [10], need to be considered in
the context of such findings.
Reported gender differences in course of illness have also
been varied. In terms of symptomatology, females may
have more severe depressive symptoms [9,10,12], more
mixed symptoms [13], psychotic symptoms including para-
noid delusions and delusions of reference [12], and be
more likely to experience rapid cycling [9]. Other studies
have found no such differences [8,14]. Polarity of the in-
cipient mood episode may also contribute to variation in
gender differences. Males with bipolar I disorder may be
more likely to have mania as their first episode whereas fe-
males are more likely to have a depressive episode [8].
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Less is known about gender differences in social and
occupational functioning, with more emphasis being
placed on symptomatology. However, Miquel et al. [15]
reported that a higher proportion of females than males
with acute mania, either lived independently or resided
with a partner. No gender differences were observed in
participation in work or social activities.
Unrepresentative and small samples may contribute to
the variability in findings on gender differences in bipo-
lar disorder. Often chronic patients or inpatients have
been recruited; such cohorts have experienced a broad
range of primary stressors prior to illness as well as sec-
ondary stressors associated with the illness (e.g., acute
illness phases, relapses and medication).
To date, research on the gender differences in patients
with first episode mania (FEM) is sparse. There appears
to be only one study that has involved the investigation
of gender differences in a FEM cohort. Kennedy et al.,
[7] focused on incidence across a wide age range (16 to
76 years+) and identified all adult cases with bipolar I
disorder and FEM who had been in contact with services
in a defined catchment area in south east London. They
also considered a range of psychosocial factors that may
relate to gender differences in age of onset. Males with
FEM had an earlier onset disorder than females, and
were also more likely to have a history of antisocial be-
haviour in childhood [7].
None of the studies conducted to date have examined
gender differences in the subgroup of patients who have
first episode psychotic mania (FEPM). Indeed, approxi-
mately 50% of patients will have psychotic symptoms at
some stage of their illness [16]. Further, as around 70%
of clients with bipolar disorder have incipient symptoms
before the age of 25 years [17], it is important to con-
sider whether there are gender differences in young
adults with FEPM in terms of premorbid histories, entry
characteristics, treatment, and discharge characteristics.
Therefore, in the current study, we report on gender
differences in illness course of an epidemiologically rep-
resentative treated cohort of patients with FEPM, aged
between 15–29 years of age. It was hypothesized that
there would be gender differences in clinical and func-
tional characteristics of patients presenting with FEPM.
Method
Sample and setting
One hundred and eighteen patients with a discharge diag-
nosis of FEPM were selected from a larger cohort of pa-
tients with first episode psychosis (FEP) from the First
Episode Psychosis Outcome Study (FEPOS). FEPOS com-
prised a file audit of all 786 FEP patients treated at the Early
Psychosis Prevention and Intervention Centre (EPPIC) be-
tween January 1998 and December 2000 [1,18-27]. EPPIC
provides a comprehensive specialist program for young
people aged 15–29 years experiencing their first episode of
psychosis. Its catchment area covers the north-western re-
gions of Melbourne, Australia [28]. At the time of the
study, EPPIC treated most patients with psychosis, with
very little leakage into the private system [20]. On the basis
of these characteristics, FEPOS has been considered to
comprise a treated epidemiological cohort [20].
Institutional ethics approval was obtained from Mental
Health Research and Ethics Committee, Melbourne
Health, Victoria, Australia. As this was a medical file
audit study, informed consent was not required to be
obtained from patients.
Materials and procedure
The Early Psychosis File Questionnaire [20] was used to
systematically assess consecutive medical files.
Clinical diagnoses at EPPIC are derived through con-
sensus during an intensive diagnostic and treatment
process. An initial diagnosis is determined during the
first 6 weeks of admission by the team of well-trained
clinicians, and is reviewed over the course of treatment.
FEPOS diagnoses were given according to DSM-IV and
on the basis of all information detailed in the medical
file [20]. Given the issues with diagnostic instability in
early illness course, we used final discharge diagnosis to
identify the cohort of FEPM patients used in the current
study [23].
Pre-morbid characteristics recorded included: past his-
tory of DSM-IV psychiatric disorder; past history of DSM-
IV substance use disorder; suicide attempts (classified on
ICD-10 criteria); family history of psychiatric disorder; pre-
morbid adjustment as assessed by the Global Assessment
of Functioning (GAF); age at onset of psychotic symptoms;
and duration of untreated psychosis (age of entry into
EPPIC subtracted by age when first sustained positive
psychotic symptoms longer than a week duration).
At service entry, clinical diagnoses (including substance
use) were ascertained according to DSM-IV criteria. Illness
severity was assessed according to scores on the Clinical
Global Impressions–Severity of Illness Scale [29] and the
Clinical Global Impressions-Bipolar Illness (CGI-BP).
Insight was coded on a three point scale (0 ‘absence of
insight; 1 ‘partial insight–perception of being ill but per-
sistence of illogical explanations’; and 2 ‘full insight’).
Global functioning was assessed using the GAF. Voca-
tional functioning was determined using the Modified
Vocational Status Index (MVSI) and the Modified Loca-
tion Code Index (MLCI) was used to determine inde-
pendent living status [30].
Treatment information included: suicide attempts; in-
patient admissions; medication non-compliance (≥1 week
without taking medication); and service engagement.
At service discharge, the final file DSM-IV clinical diag-
noses were recorded. Symptom severity was determined
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using CGI-S, CGI-BP, and the insight scale. The GAF,
MVSI, and MLCI, were used to assess discharge functional
status. Patterns of substance use over treatment was also
documented and characterised by three categories: (i) no
SUD; (ii) decreased or remitted (decrease in quality and
frequency of ≥50% or remission of baseline at 18 months
or time of discharge); and (iii) persistent SUD (either in-
creased SUD or unchanged SUD) [20].
Reliability and validity
Estimates obtained for inter-rater reliability for the CGI,
CGI-BP, GAF, and insight for 40 files were good (range:
κ = 0.87 for CGI-S to κ = 0.89 for insight score) [20].
The SCID-I/P was used to determine the validity of
diagnoses for a subset of 115 patients (see Conus et al.,
2007). There was good concordance for both psychotic
(κ = 0.80) and substance use (κ = 0.74) diagnoses.
Data analysis
A series of logistic regression analyses were conducted
with gender as the dependent variable (male as the refer-
ence category), and the individual premorbid and service
entry variables as predictors. From these analyses, odds
ratios (OR) and the 95% confidence intervals (CI) of the
ORs were derived. The Wald statistic (z) was used to de-
termine significance of predictors. For the treatment and
discharge variables, adjusted ORs and 95% CI of the ad-
justed ORs were reported, controlling for entry charac-
teristics and time in service.
Multivariate logistic regression with forward stepwise
variable selection (based on the likelihood ratio) was
used to determine which factors best differentiated
males and females with FEPM. Variables included in the
equation were those that were different by gender in the
univariate analyses at the p < .100 level.
Given the exploratory nature of the study, alpha (α) was
set at .05 for all analyses. No adjustments were made for
multiple comparisons because they can result in a higher
type II rate, reduced power, and increased likelihood of
missing important findings (Rothman, 1990).
Results
The majority of patients were male (60.2%, n = 71).
Given the ratio of males to females, we had around 75%
power to detect moderate effects (differences between
the two genders). Previous studies of gender differences
in psychotic disorders have reported moderate to large
effects [1]; thus we had an adequate sample size to
power the study.
The average age of onset of illness was 22.2 years (SD =
3.2, min = 15, max = 29) and the average age at entry to
the service was 22.4 years (SD = 3.2, min = 15, max = 30).
Males with FEPM were more likely to have a past his-
tory of substance use (OR = 4.86, p < .001) and forensic
issues (OR = 14.79, p = .008). Females with FEPM were
more likely to have experienced sexual abuse trauma
(OR = 7.12, p = .001)a (see Table 1).
At service entry, males were significantly more likely to
have substance use issues (OR = 3.98, p = .001); with can-
nabis use prominent (OR = 4.58, p = .047). Males also had
more severe illness (CGI-S, OR = 1.72, p = .037) and
poorer functioning (GAF, OR = 0.96, p = .045) compared
to females with FEPM (see Table 1). During treatment
males with FEPM were more likely to decrease or stop
their substance use (OR = 5.34, p = .008) than females
with FEPM. At discharge males were more likely to be liv-
ing with their families (OR = 4.30, p = .009), but there
were no gender differences in discharge psychopathology
or functioning (see Table 2).
A range of variables in the univariate analyses distin-
guished males and females at the p < .100 level includ-
ing: past history of substance use; exposure to sexual
abuse; forensic issues; substance use at service entry;
CGI-S at entry; GAF at entry; admissions to hospital;
substance use at discharge; and whether or not living
with a family at discharge. These variables were entered
into a multivariate logistic regression model to deter-
mine which factors best delineated differences between
males and females. Past history of substance use (OR =
20.33, 95% CI OR 6.13-67.42, p < .001), exposure to sex-
ual abuse (OR = 0.11, 95% CI OR 0.02-0.53, p = .006),
and living with family at discharge (OR = 3.33, 95% CI
OR 1.06-10.41, p = .039) were the variables that best dis-
criminated between males and females with FEPM.
Discussion
To our knowledge, this the first study to comprehen-
sively examine gender differences in illness onset and
course in a treated epidemiological cohort of patients
with FEPM. A further strength of the study is that we in-
cluded all patients who first presented for treatment and
not just those patients with more severe or chronic ill-
ness or those who have had their first inpatient admis-
sion. Similar to previous studies into patients with chronic
illness and bipolar I disorder, we found an array of gender
differences in patients with FEPM between the ages of 15
to 29 years. Key differences were found with respect to
premorbid history, severity of illness at entry, treatment
and discharge characteristics.
Univariate analyses indicated that males with FEPM
were more likely to have a history of substance and fo-
rensic issues. It has previously been shown that males
with bipolar disorder are more likely to have conduct
problems or antisocial tendencies in childhood [7,8]
which may increase the likelihood of violence [31] and
problems with the law [14,32]. Substance use (especially,
alcohol, cannabis and nicotine) also tends to be more
common in males than females with bipolar disorder
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[9,10,15,33], and might explain the increased prevalence
of forensic issues [34] in our cohort.
Gender differences in the prevalence of substance use
disorders have been reported in the general population,
with males being more likely to abuse or be dependent
on drugs [35]. At service entry, 74.6% of males and
42.6% of females were using substances; much higher
than rates in the general population. The persistent sub-
stance use in males, particularly prior to, and at the
onset of the psychotic mania, might in part explain their
more severe levels of psychopathology and poorer func-
tioning (as measured by the GAF). This is supported by
findings that substance use in patients with bipolar dis-
order is associated with poorer social adjustment and
outcome [36].
Males were more likely to use cannabis than females
with FEPM; but no such gender differences were found
with alcohol or polysubstance use. Cannabis use is
Table 1 Demographic, diagnostic, premorbid, pre-treatment and service entry factors related to gender in FEPM patients
Gender 95% CI of OR p value
Male Female OR LCI UCI
Variable (n=71) (n=47)
Pre-treatment variables
Years in school M (SD) 11.2 (1.3) 11.0 (1.6) 1.12 0.86 1.45 .395
Pre-morbid GAF M (SD) 73.9 (11.5) 74.8 (9.4) 0.99 0.96 1.03 .638
Duration of prodrome (in days) a M (SD) 363.0 (640.0) 227.2 (338.0) 1.15 0.83 1.60 .398
Duration of untreated psychosis (in days) a M (SD) 41.4 (197.2) 64.93 (190.9) 0.76 0.50 1.16 .204
Age at onset (years) M (SD) 22.0 (3.0) 22.5 (3.6) 0.95 0.85 1.07 .387
Past history of suicide attempt (%Yes) % (n) 2.8 (2) 8.7 (4) 0.30 0.05 1.73 .180
Family history of psychiatric disorder % (n) 60.9 (42) 72.1 (31) 0.60 0.26 1.37 .227
Diagnostic variables
Past history
Major depressive disorder % (n) 49.3 (35) 63.8 (30) 0.55 0.26 1.17 .122
Substance use disorder (SUD) (%Yes) % (n) 91.5 (65) 44.7 (21) 13.41 4.86 37.01 <.001
Sexual abuse % (n) 5.6 (4) 29.8 (14) 0.14 0.04 0.46 .001
Physical abuse % (n) 14.1 (10) 19.1 (9) 0.69 0.26 1.86 .465
Forensic issues % (n) 30.4 (21) 8.5 (4) 4.71 1.50 14.79 .008
At service entry
Comorbid psychiatric disorder (%Yes) % (n) 4.2 (3) 4.3 (2) 1.01 0.16 6.27 .994
Substance use disorder (SUD) (%Yes) % (n) 74.6 (53) 42.6 (20) 3.98 1.81 8.74 .001
Cannabis % (n) 54.9 (39) 36.2 (17) 2.15 1.01 4.58 .047
Alcohol % (n) 11.3 (8) 12.8 (6) 0.87 0.28 2.68 .805
Polysubstance % (n) 14.1 (10) 8.5 (4) 1.76 0.52 5.99 .364
Baseline variables
Age at service entry M (SD) 22.3 (3.0) 22.7 (3.4) 0.96 0.85 1.08 .469
Symptoms at entry
CGI-S severity score M (SD) 5.8 (0.8) 5.5 (0.7) 1.72 1.03 2.86 .037
CGI-BP depression M (SD) 1.5 (1.3) 1.4 (1.3) 1.11 0.81 1.51 .520
CGI-BP mania M (SD) 4.7 (1.8) 4.6 (1.5) 1.05 0.84 1.31 .657
Insight at entry (%No) % (n) 76.1 (54) 65.2 (30) 1.69 0.75 3.83 .205
Functional level at entry
Employment/occupation (%Yes) % (n) 63.4 (45) 72.3 (34) 0.66 0.30 1.47 .312
GAF M (SD) 29.7 (10.1) 33.5 (9.1) 0.96 0.92 0.99 .045
Living with family % (n) 54.3 (38) 44.7 (21) 1.47 0.70 3.09 .309
Note: OR - odds ratio; LCI - lower confidence interval; UCI - upper confidence interval; CGI-S - Clinical Global Impressions Scale - Severity; CGI-BP - Clinical Global
Impressions Scale - Bipolar Disorder; GAF - Global Assessment of Functioning.
a Raw data are presented, however the test statistics were based on log10 (+constant) transformed data because of extreme positive skewness.
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common in patients with bipolar disorder, particularly in
younger patients (< 30 years) [37,38]. Cannabis use may
be associated with an earlier age of onset of bipolar dis-
order, particularly in vulnerable individuals [38]. However,
no such gender differences in age of onset were found in
the current study cohort.
During treatment, males were more likely than females
to decrease or cease their substance use. Increased fa-
milial support in males might have contributed to the
reduction of substance use. Males who are ill with a first
episode of psychosis are more likely than females to re-
ceive understanding and support from family members
[39]. This may relate to cultural and societal differences
in that underperformance and behavioural issues are tol-
erated more in males than females [39]. Further, females
with psychotic disorders such as schizophrenia are more
likely to have experienced childhood adversities [40],
and are hence likely to leave home at an early age.
Family involvement in early treatment can be pertinent
for minimising the chances of substance use becoming a
more serious disorder [41-43]. An alternative explan-
ation might be that the percentage of males who live
with their families increases when they stop using sub-
stances. The decrease in substance use in males may also
account for why there are no differences between the
genders in terms of severity of illness and functioning at
discharge.
Females were seven times more likely to have experi-
enced sexual abuse than males with FEPM. A recent
meta analysis indicated that the prevalence of sexual
abuse is higher in females (19.7%) than males (7.9%) in
the general population [44]. However, in our sample ap-
proximately 30% of females with FEPM had been ex-
posed to sexual abuse; a rate of trauma that is of
concern. A relationship between sexual abuse or trau-
matic experiences and the onset of psychotic disorders
Table 2 Treatment and discharge characteristics of males and females with FEPM
Gender 95% CI of OR p value
Male Female OR LCI UCI
Variable (n=71) (n=47)
Treatment variables
Length of time in service (in weeks) M (SD) 64.8 (34.1) 59.1 (30.1) 1.01 0.99 1.02 .353
Admitted to hospital (%Yes) a % (n) 91.5 (65) 80.9 (38) 2.71 0.89 8.30 .080
Number of admissions a M (SD) 1.5 (1.1) 1.2 (0.8) 1.36 0.88 2.10 .173
Compliance with treatment (%Yes) a % (n) 56.5 (39) 50.0 (21) 1.28 0.59 2.77 .533
Substance use disorder (SUD) a b
No SUD % (n) 23.9 (17) 55.3 (26) na
Remitted SUD (decreased or stopped) % (n) 56.3 (40) 25.5 (12) 5.34 2.17 13.14 <.001
Persistent SUD (increased or no change) % (n) 19.7 (14) 19.1 (9) 2.93 0.97 8.89 .056
Suicide attempt in treatment (%Yes) a % (n) 7.0 (5) 4.3 (2) 1.51 0.27 8.32 .639
Symptoms at discharge
CGI-S severity score c M (SD) 2.2 (1.2) 2.2 (1.2) 0.99 0.69 1.42 .950
CGI-BP depression d M (SD) 1.4 (0.9) 1.4 (1.0) 0.99 0.65 1.49 .953
CGI-BP mania e M (SD) 1.4 (1.0) 1.5 (1.0) 1.03 0.65 1.64 .890
Insight at discharge (%No) f % (n) 7.0 (5) 4.3 (2) 1.88 0.32 11.14 .485
Functional level at discharge
Employment/occupation (%Yes) g % (n) 56.5 (35) 72.5 (29) 0.50 0.19 1.31 .158
GAF h M (SD) 68.8 (14.6) 71.1 (12.3) 0.99 0.96 1.02 .446
Living with family (%Yes) ' M (SD) 77.0 (47) 51.3 (20) 4.30 1.44 12.79 .009
Note: OR - odds ratio; LCI - lower confidence interval; UCI - upper confidence interval; CGI-S - Clinical Global Impressions Scale - Severity; CGI-BP - Clinical Global
Impressions Scale - Bipolar Disorder; GAF - Global Assessment of Functioning.
a Covariate was time in service.
b No substance use was reference category in logistic regression.
c Covariates were time in service and CGI-S at entry, unadjusted means and standard deviations are reported.
d Covariates were time in service and CGI-BP depression at entry, unadjusted means and standard deviations are reported.
e Covariates were time in service and CGI-BP mania at entry, unadjusted means and standard deviations are reported.
f Covariates were time in service and insight at service entry.
g Covariates were time in service and employment status at entry.
h Covariates were time in service and GAF score at entry.
i Covariates were time in service and living with family at service entry.
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has been proposed [45-48], and this association may be
stronger in females than males [49]. Exposure to such
trauma, may negatively affect brain development,
through chronic hyper-reactivity of the hypothalamic-
pituitary-adrenal (HPA) axis. This hyper-reactivity may
then lead to disruption in the functions of dopaminergic
and serotonergic systems, and may worsen prognosis.
Such events sequelae have been described in the
“traumagenic neurodevelopmental” model. Although the
ultimate alterations to functions in dopaminergic and se-
rotonergic may precipitate the onset of FEPM, there
may be broader long-term effects. In females with
chronic bipolar disorder, a history of sexual and physical
abuse/trauma may relate to poorer mood outcomes such
as more shifts in polarity and mixed episodes [50]. Ex-
posure to sexual abuse might also place females with bi-
polar disorder at a disproportionately greater risk of
comorbid anxiety disorders such as post-traumatic stress
disorder (PTSD) [14,47,48,51]. Because our cohort was
young, the possibility of the development of such (gener-
ally) longer-term sequelae might not have been captured
in this group.
A history of sexual abuse may also explain why females
with FEPM were less likely to be living with their families
at discharge from the service. If the abuse occurred within
the context of the family networks, then this is a unsur-
prising finding. However, it should also be noted, a history
of sexual abuse and/or trauma is linked with markedly
poorer social functioning especially with respect to build-
ing constructive and trusting relationships [52].
With regards to the characteristics of the current
study, a number of factors need to be kept in mind in
interpreting the data. FEPM cohorts may offer a unique
window into the disorder, as the effects of illness pro-
gression and treatment are controlled for. The primary
limitation of this study is the use of a retrospective med-
ical file audit. There can be numerous problems with
such an approach including: (i) poor quality of docu-
mented information; (ii) clinical experience of raters; (iii)
lack of inter-rater reliability; and (iv) questionable data
validity. Numerous strategies were adopted in the
current study to minimise the impact of such limitations
including: (i) medical files at EPPIC were systematised
according to FEP guidelines [53]; (ii) medical files were
rated by two consultant psychiatrists with expertise
knowledge of EPPIC and the treatment of FEP; (iii)
sound inter-rater reliability was determined for clinical
and functioning measures; and (iv) concurrent validity of
psychoses and baseline SUD was established for a sub-
sample of patients [20]. The study population was a
catchment area sample, and is likely to be broadly repre-
sentative of the population of FEPM (16).
A further study limitation was the lack of information
recorded regarding psychopathology (e.g., mood episodes,
psychotic symptoms, relapse) and type and dosage of
pharmacological treatments; these factors could have
had an effect on the degree of gender difference at
discharge.
Conclusions
It appears that there are substantial differences between
males and females with FEPM in terms of past histories,
presentation, and discharge outcomes; however, these
differences may be driven by putative risk factors such
as substance use and exposure to sexual abuse. Import-
antly, these risk factors occur prior to the onset of full
threshold disorder. These risk factors might be markers
of a disease that has already been under development for
some time. However, given current evidence, it is diffi-
cult to ascertain whether substance abuse and/or sexual
abuse are a cause or consequence (e.g., prodromal phase
of illness) of illness.
There is growing interest in identifying individuals at
“ultra high risk” of developing bipolar disorder [54] and
who have a clearly defined prodrome [55,56]. It has been
argued that symptoms alone are unlikely to be sufficient
for the correct identification of those at risk of develop-
ing bipolar disorder; however, identifying risk factors or
markers of vulnerability may improve the accuracy of
this prediction [55]. The substance use and sexual abuse
findings from the current study may be considered such
gender specific risk factors that increase the likelihood
of developing FEPM and bipolar disorder. Such informa-
tion could be used by clinicians working with such “high
risk” individuals to identify those who might be at the
greatest risk of developing first psychotic manic episode.
Future research could also be directed to whether there
are gender differences in pharmacological response in
patients who are either at high risk or have full threshold
disorder.
Endnote
aFor ease of interpretation, female was the reference cat-
egory for the calculation of this odds ratio.
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